Factors associated with preventability, predictability, and severity of adverse drug reactions

被引:66
作者
Gholami, K [1 ]
Shalviri, G
机构
[1] Univ Tehran Med Sci, Dept Clin Pharm, Coll Pharm, Tehran, Iran
[2] Minist Hlth, Adverse Drug React Monitoring Ctr, Tehran, Iran
关键词
adverse drug reactions; Iran;
D O I
10.1345/aph.17440
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To determine the rate of adverse drug reactions (ADRs) in hospitalized patients in an iranian hospital and to assess factors associated with preventability: predictability, and severity of ADRs. DESIGN AND PARTICIPANTS: A prospective, randomized study was conducted on 370 patients in a hospital at the Tehran Medical Sciences University, from March to December 1996. Patients who experienced at least one ADR (n = 62) were entered into the database. Preventability, predictability. and severity of reactions were determined, based on the available algorithms developed by other investigators. SETTING: A 1200-bed tertiary; care university teaching hospital in Tehran, Iran. RESULTS: Approximately 16.8% (n = 62) of the 370 patients who were included in this study had at least one ADR. One hundred two ADRs were reported during this study. Approximately 58.8% of the ADRs (60 reactions) were identified as preventable reactions and 96.1% as predictable reactions. The severity of 9.8% of the ADRs was identified as mild, 86.3% as moderate, 1% as severe, and 2.9% as lethal. The length of hospitalization increased with the severity of the ADRs. Preventable ADRs were more severe than those that were nonpreventable. In addition, the incidence of preventable ADRs increased with the patients' age and caused longer hospitalization than did nonpreventable ones. The most predictable ADRs were hematologic. CONCLUSIONS: Tills study noted that the rate of, ADRs in Iran is probably as high as the rate in other parts of the world. These results indicate a need for a strong national ADR program that detects and reports adverse drug events in Iran.
引用
收藏
页码:236 / 240
页数:5
相关论文
共 17 条
[1]  
BOSH TK, 1992, 49 AM SOC HOSP PHARM
[2]  
BREATHNACH SM, 1992, ADVERSE DRUG REACT, P14
[3]   INCIDENCE OF ADVERSE EVENTS AND NEGLIGENCE IN HOSPITALIZED-PATIENTS - RESULTS OF THE HARVARD MEDICAL-PRACTICE STUDY-I [J].
BRENNAN, TA ;
LEAPE, LL ;
LAIRD, NM ;
HEBERT, L ;
LOCALIO, AR ;
LAWTHERS, AG ;
NEWHOUSE, JP ;
WEILER, PC ;
HIATT, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (06) :370-376
[4]   PREVENTABILITY OF ADVERSE DRUG-REACTIONS [J].
BURNUM, JF .
ANNALS OF INTERNAL MEDICINE, 1976, 85 (01) :80-81
[5]  
Clyne KE, 1992, PHARMACOL THERAPEUT, V17, P1145
[6]  
DAVIES DM, 1981, TXB ADVERSE DRUG REA
[7]   DRUG ALLERGY - PROBLEMS AND STRATEGIES [J].
DESWARTE, RD .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1984, 74 (03) :209-221
[8]   PREVENTABILITY AND SEVERITY ASSESSMENT IN REPORTING ADVERSE DRUG-REACTIONS [J].
HARTWIG, SC ;
SIEGEL, J ;
SCHNEIDER, PJ .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1992, 49 (09) :2229-2232
[9]   MEDICATION USE IN AN IMPERFECT WORLD - DRUG MISADVENTURING AS AN ISSUE OF PUBLIC-POLICY .1. [J].
MANASSE, HR .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1989, 46 (05) :929-944
[10]  
MELMON KL, 1971, NEW ENGL J MED, V284, P1361